(Reuters)—On April, the U.S. Food and Drug Administration (FDA) cautioned against the use of malaria drug hydroxychloroquine (HCQ) in COVID-19 patients even as President Donald Trump, who has touted it as a “game changer,” advocated for an additional review. The drug, first approved in 1955, provided no benefit and potentially higher risk of death for…
Search results for: hospital
On Pandemics & Uncertainty: One Rheumatologist’s Story
As the mystery solvers, we are supposed to be comfortable with the unknown, but how does that translate when COVID-19 hits home? A rheumatologist contracts COVID-19.
Local Depletion of Resident Memory T Cells May Reduce Site-Specific Joint Flares
A study found resident memory T cells may mediate inflammatory arthritis and trigger flares in specific joints, suggesting local depletion of these cells could be a therapeutic strategy…
In Memoriam: Luis R. Espinoza, MD: July 3, 1943–March 29, 2020
Surrounded by his immediate family, Luis R. Espinoza, MD, died on March 29 after a prolonged illness.
FDA Considers Tanezumab Application for Chronic OA Pain
The FDA is considering an application for subcutaneous tanezumab, a monoclonal antibody, as a treatment for moderate to severe osteoarthritis…
Upper Limb Exercise May Improve Quality of Life for Lupus Patients
A recent study found SLE patients may improve their daily physical function, pain and overall quality of life by adding upper limb exercises to stable treatment regimens and routine care…
Forging New Ways to Teach in Response to COVID-19: Q&A with Anisha Dua, MD, MPH
Unable to connect with rheumatology fellows and patients in person, Anisha Dua, MD, MPH, and a team of rheumatologists have worked quickly to find new ways to communicate and share resources. Dr. Dua directs rheumatology medical education and the fellowship training program at Northwestern Memorial Hospital (NMH), Chicago. She spoke with The Rheumatologist about how…
Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS
The COVID-19 global pandemic is forcing telemedicine-only connections with patients and bringing existing rheumatology research to a standstill. However, these challenges are spurring opportunity and innovation, according to Vaneet K. Sandhu, MD, FACR, RhMSUS, director of rheumatology clinical operations at Riverside University Health System and associate fellowship program director in rheumatology at Loma Linda University…
Patients Need Psychosocial Support Now More Than Ever: Q&A with Adena Batterman, MSW, LCSW
How are rheumatology professionals affected by the physical distancing and other challenges presented by COVID-19? The Rheumatologist interviewed Adena Batterman, MSW, LCSW, senior manager of inflammatory arthritis support and education programs at the Hospital for Special Surgery, New York, to discuss how the pandemic has changed the way she and her staff maintain continuity of…
The COVID-19 Crisis: Uncharted Waters & the ACR’s Response
Singer Jimmy Dean reportedly once said, “I can’t change the direction of the wind, but I can adjust my sails to always reach my destination.” The COVID-19 pandemic has required us as rheumatologists to adjust our sails multiple times. We have had to rethink many of the ways in which we interact with our worried…
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 330
- Next Page »